Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia

1. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.Search in Google Scholar

2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistic, 2002. CA cancer J Clin 2005; 55: 74-108.10.3322/canjclin.55.2.7415761078Search in Google Scholar

3. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edition. New York: Springer-Verlag; 2009.Search in Google Scholar

4. Wronski M, Ziarkiewicz-Wroblewska B, Slodkowski M, Cebulski W, Gornicka B Krasnodebski IW. Mesenteric fibromatosis with intestinal involvement mimicking a gastrointestinal stromal tumour. Radiol Oncol 2011; 45: 59-63.10.2478/v10019-010-0051-7342371522933936Search in Google Scholar

5. Oblak I, Velenik V, Anderluh F, Strojan P. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia. Eur J Surg Oncol 2007; 33: 982-7.10.1016/j.ejso.2006.12.01217258881Search in Google Scholar

6. Oblak I, Anderluh Franc, Velenik V. Postoperative radiochemotherapy for gastric adenocarcinoma: long term results. Radiol Oncol 2009; 43: 274-81.10.2478/v10019-009-0035-7Search in Google Scholar

7. Power DG, Reynolds JV. Localized adenocarcinoma of the esophagogastric junction-is there a standard of care? Cancer Treatm Rev 2010; 36: 400-9.Search in Google Scholar

8. Wayman J, Bennet MK, Rames SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the oesophagogastric junction. Br J Cancer 2002; 86: 1223-9.10.1038/sj.bjc.6600252237532811953876Search in Google Scholar

9. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 2010; 28: 5210-8.10.1200/JCO.2009.26.6114302069321060024Search in Google Scholar

10. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.10.1056/NEJM1996081533507028672151Search in Google Scholar

11. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-92.10.1200/JCO.2007.12.9593512664418309943Search in Google Scholar

12. Ajani JA, Rodriguez W, Bodoky G, Moiseyenko V, Lichinitser M, Gorbunova V, et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J Clin Oncol 2010; 28: 1547-53.10.1200/JCO.2009.25.470620159816Search in Google Scholar

13. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann G, et al.. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.10.1056/NEJMoa01018711547741Search in Google Scholar

14. Kim S, Lim DH, Lee J, Kang WK, MacDonald S, Park CH, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Bio Phys 2005; 63: 1279-85.10.1016/j.ijrobp.2005.05.005Search in Google Scholar

15. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 335: 11-20.10.1056/NEJMoa055531Search in Google Scholar

16. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011; 29: 1715-21.10.1200/JCO.2010.33.0597Search in Google Scholar

17. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27: 851-6.10.1200/JCO.2008.17.0506Search in Google Scholar

18. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-34.10.1016/S1470-2045(07)70039-6Search in Google Scholar

19. Fok M, Sham JS, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993; 173: 138-47.Search in Google Scholar

20. Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French university association for surgical research. Surg Gynecol Obstet 1991; 173: 123-30.Search in Google Scholar

21. Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 2009; 96: 23-33.Search in Google Scholar

22. Liu TS, Wang Y, Chen SY, Sun YH. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol 2008; 34: 1208-16.10.1016/j.ejso.2008.02.00218353606Search in Google Scholar

23. Ajani JA, Welch SR, Raber MN, Fiels WS, Krakoff IM. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990; 8: 147-59.10.3109/073579090090175602400936Search in Google Scholar

24. ICRU 50: Prescribing, recording, and reporting photon beam therapy. Bethesda: International Commission on Radiation Units and Measurements Press; 1993.Search in Google Scholar

25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.10.1080/01621459.1958.10501452Search in Google Scholar

26. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.10.1038/bjc.1977.12025310831755Search in Google Scholar

27. Cox DR. Regression models and life-tables. J R Stat Soc Bull 1972; 34: 187-220.10.1111/j.2517-6161.1972.tb00899.xSearch in Google Scholar

28. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.10.1056/NEJMra035010Search in Google Scholar

29. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from 18 major cancers in 1985. Int J Cancer 1993; 55: 891-903.10.1002/ijc.2910550604Search in Google Scholar

30. Torrente S, Turri L, Deantonio L, Cena T, Gambaro G, Magnani C, et al. Concomitant chemo-radiotherapy for unresectable oesophageal cancer: A mono-institutional study on 40 patients. Rep Pract Oncol Radiother 2012; 17: 226-32.10.1016/j.rpor.2012.03.013Search in Google Scholar

31. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, et al. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol 2009; 4: 1264-9.10.1097/JTO.0b013e3181b26f8eSearch in Google Scholar

32. Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 2006; 15: 751-64.10.1016/j.soc.2006.07.015Search in Google Scholar

33. Weitz J, Jaques DP, Brennan M, Karpeh M. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer. Ann Surg Oncol 2004; 11: 682-9.10.1245/ASO.2004.03.048Search in Google Scholar

34. Pultrum BB, van Bastelaar J, Schreurs MA, van Dullemen HM, Groen H, Nijsten MWN, et al. Impact of splenectomy on surgical outcome in patients with cancer of the distal esophagus and gastro-esophageal junction. Dis Esophagus 2008; 21: 334-9.10.1111/j.1442-2050.2007.00762.xSearch in Google Scholar

35. Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006; 24: 4347-55.10.1200/JCO.2005.04.9445Search in Google Scholar

36. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the US. Cancer 2002; 95: 1434-43.10.1002/cncr.10868Search in Google Scholar

37. Steup WH, de Leyn P, Deneffe G, van Raemdonck D, Coosemans W, Lerut T. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 1996; 111: 85-94.10.1016/S0022-5223(96)70404-XSearch in Google Scholar

38. Mariette C, Taillier G, van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 2004; 78: 177-83.10.1016/j.athoracsur.2004.02.06815464466Search in Google Scholar

39. Lerut T, Coosemans W, Decker G, de Leyn P, Moons J, Nafteux P, et al. Extended surgery for cancer of the esophagus and gastroesophageal junction. J Surg Res 2004; 117: 58-63.10.1016/j.jss.2003.12.01215013715Search in Google Scholar

40. Predrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 2007; 134: 378-85.10.1016/j.jtcvs.2007.03.03417662776Search in Google Scholar

41. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg 2000; 232: 353-61.10.1097/00000658-200009000-00007142114910973385Search in Google Scholar

42. Crumley ABC, Stuart RC, McKernan M, Going JJ, Shearer CJ, McMilan DC. Comparison of the pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system. J Gastrointest Surg 2010; 14: 781-7.10.1007/s11605-010-1162-620148314Search in Google Scholar

43. Deans DAC, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S, et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009; 100: 63-9.10.1038/sj.bjc.6604828263468619127266Search in Google Scholar

44. Stahl M, Wilke H, Stuschke M, Walz MK, Fink U, Molls M, et al. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. J Cancer Res Clin Oncol 2005; 131: 67-72.10.1007/s00432-004-0604-515480782Search in Google Scholar

45. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DB, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. . N Engl J Med 1998; 339: 1979-84.10.1056/NEJM1998123133927049869669Search in Google Scholar

46. Plaisant N, Senesse P, Azria D, Lemanski C, Ychou M, Quenet F, et al. Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results. World J Surg 2005; 29: 32-8.10.1007/s00268-004-7455-815592917Search in Google Scholar

47. Kovac V, Zwitter M, Zagar T. Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients. Radiol Oncol 2012; 46: 136-44.10.2478/v10019-012-0032-0347293823077450Search in Google Scholar

48. Leigh Y, Seagroatt V, Goldacre M, McCulloch P. Impact of socio-economic deprivation on death rates after surgery for upper gastrointestinal tract cancer. Br J Cancer 2006; 95: 940-3.10.1038/sj.bjc.6603315236052716926832Search in Google Scholar

49. Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 2002; 9: 210-4.10.1007/BF0255737611888881Search in Google Scholar

50. McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008; 98: 888-93.10.1038/sj.bjc.6604248226685918268490Search in Google Scholar

51. Sauvanet A, Mariette C, Thomas P, Lozac’h P, Segol P, Tiret E, et al. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg 2005; 201: 253-62.10.1016/j.jamcollsurg.2005.02.00216038824Search in Google Scholar

52. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-30.10.1038/sj.bjc.6690243236274210188901Search in Google Scholar

53. Schmid A, Thybusch A, Kremer B, Henne-Bruns D. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients. Hepatogastroenterology 2000; 47: 579-85.Search in Google Scholar

54. Huang CM, Wang JB, Lu HS, Zheng CH, Li P, Xie JW, et al. Prognostic impact of splenectomy on advanced proximal gastric cancer with more than 10 lymph node metastasis. Chin Med J 2009; 122: 2757-62.Search in Google Scholar

55. Buyukasik O, Hasdemir AO, Gulnerman Y, Col1 C, Ikiz O. Second primary cancers in patients with gastric cancer. Radiol Oncol 2010; 44: 239-43.10.2478/v10019-010-0048-2342370722933922Search in Google Scholar

56. Ikequchi M, Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer. Am Surg 2004; 70: 645-8.10.1177/000313480407000716Search in Google Scholar

57. Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol 2012; 18: 1216-28.10.3748/wjg.v18.i11.1216330991122468085Search in Google Scholar